Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 18/09/19 → 31/10/21 |
Keywords
- Neuroscience
- Huntington's Disease
- Clinical trial
Clinical Trial Phase
- Phase I
- Phase II
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120102 Administered Intrathecally in Patients with Huntington's Disease.
- O'Brien, Terence (Primary Chief Investigator (PCI))
- Bertram, Kelly (Chief Investigator (CI))
- Burn, Katherine (Project Manager)
Project: Research